Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Magnetic Resonance Imaging (MRI) Follow-up of Macrophagic Infiltration in MS Patients Treated With Tysabri

This study has been terminated.
Information provided by (Responsible Party):
University Hospital, Strasbourg, France Identifier:
First received: September 11, 2008
Last updated: November 9, 2012
Last verified: November 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2011
  Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)